{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:23:58Z","timestamp":1790274238959,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejpb.2022.09.022","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T11:03:29Z","timestamp":1665227009000},"page":"149-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["DoE-based development of celecoxib loaded PLGA nanoparticles: In ovo assessment of its antiangiogenic effect"],"prefix":"10.1016","volume":"180","author":[{"given":"Mario","family":"Alonso-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fern\u00e1ndez-Carballido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prissila","family":"Quispe-Chauca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mart\u00edn-Sabroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Isabel Fraguas-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejpb.2022.09.022_b0005","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1096\/fj.202000380RR","article-title":"The role of CD44 in pathological angiogenesis","volume":"34","author":"Chen","year":"2020","journal-title":"Faseb J."},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.022_b0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10456-019-09689-7","article-title":"Role of melatonin in controlling angiogenesis under physiological and pathological conditions","volume":"23","author":"Ma","year":"2020","journal-title":"Angiogenesis"},{"issue":"9","key":"10.1016\/j.ejpb.2022.09.022_b0015","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2022.09.022_b0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10456-015-9477-2","article-title":"The pathogenic role of angiogenesis in rheumatoid arthritis","volume":"18","author":"Elshabrawy","year":"2015","journal-title":"Angiogenesis"},{"issue":"6","key":"10.1016\/j.ejpb.2022.09.022_b0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2217\/bmm.15.125","article-title":"Characteristics of resistin in rheumatoid arthritis angiogenesis","volume":"10","author":"Su","year":"2016","journal-title":"Biomarkers Med."},{"issue":"8","key":"10.1016\/j.ejpb.2022.09.022_b0030","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1002\/ptr.7130","article-title":"Geniposide downregulates the VEGF\/SphK1\/S1P pathway and alleviates angiogenesis in rheumatoid arthritis in vivo and in vitro","volume":"35","author":"Wang","year":"2021","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.022_b0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.23938\/ASSN.0965","article-title":"Safety considerations during prescription of non-steroidal anti-inflammatory drugs (NSAIDs), through a review of systematic reviews","volume":"44","author":"de Labry","year":"2021","journal-title":"An. Sist. Sanit. Navar."},{"key":"10.1016\/j.ejpb.2022.09.022_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"Bindu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2022.09.022_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112983","article-title":"Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis","volume":"210","author":"Consalvi","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejpb.2022.09.022_b0050","unstructured":"B. Cohen, C.V. Preuss, Celecoxib, in: StatPearls, StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC.: Treasure Island (FL), 2022."},{"issue":"12","key":"10.1016\/j.ejpb.2022.09.022_b0055","doi-asserted-by":"crossref","first-page":"696","DOI":"10.5414\/CP203757","article-title":"Synergistic effect of bevacizumab and celecoxib on angiogenesis in vitro using human umbilical vein endothelial cells","volume":"58","author":"Qadir","year":"2020","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ejpb.2022.09.022_b0060","first-page":"2858","article-title":"Celecoxib reduces inflammation and angiogenesis in mice with adenomyosis","volume":"13","author":"Liang","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"5","key":"10.1016\/j.ejpb.2022.09.022_b0065","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1517\/13543784.2016.1161756","article-title":"Celecoxib for the treatment of atherosclerosis","volume":"25","author":"Papageorgiou","year":"2016","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"7","key":"10.1016\/j.ejpb.2022.09.022_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/ph15070827","article-title":"Selective COX-2 inhibitors: road from success to controversy and the quest for repurposing","volume":"15","author":"El-Malah","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejpb.2022.09.022_b0075","unstructured":"Information., N.C.f.B., \u201cPubChem Compound Summary for CID 2662, Celecoxib\u201d PubChem,https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Celecoxib. Accessed 14 April, 2022. 2022."},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.022_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020290","article-title":"Modulation of inflammatory mediators by polymeric nanoparticles loaded with anti-inflammatory drugs","volume":"13","author":"Pontes-Quero","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2022.09.022_b0085","first-page":"71","article-title":"Development of a novel intraarticular injection of diclofenac for the treatment of arthritis: a preclinical study in the rabbit model","volume":"68","author":"Wen","year":"2021","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejpb.2022.09.022_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119378","article-title":"Intra-articular multifunctional celecoxib loaded hyaluronan nanocapsules for the suppression of inflammation in an osteoarthritic rat model","volume":"583","author":"El-Gogary","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2022.09.022_b0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.34172\/apb.2020.049","article-title":"Formulation and in vitro evaluation of casein nanoparticles as carrier for celecoxib","volume":"10","author":"Madan","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2022.09.022_b0100","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.biopha.2018.04.079","article-title":"In vivo evaluation of antitumoral and antiangiogenic effect of imiquimod-loaded polymeric nanoparticles","volume":"103","author":"Dias","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.022_b0105","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s43440-021-00218-2","article-title":"Evaluation of curcumin-loaded polymeric nanocapsules with different coatings in chick embryo model: influence on angiogenesis, teratogenesis and oxidative stress","volume":"73","author":"de Carvalho","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejpb.2022.09.022_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118916","article-title":"CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer","volume":"574","author":"Fraguas-S\u00e1nchez","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.09.022_b0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejps.2018.08.038","article-title":"Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline","volume":"124","author":"Rawal","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2022.09.022_b0120","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1080\/10717544.2017.1359862","article-title":"Nanotechnology-based drug delivery of ropinirole for Parkinson\u2019s disease","volume":"24","author":"Barcia","year":"2017","journal-title":"Drug Delivery"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2022.09.022_b0125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijpharm.2014.07.028","article-title":"New celecoxib multiparticulate systems to improve glioblastoma treatment","volume":"473","author":"Vera","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2022.09.022_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12050439","article-title":"PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: in vitro and in Ovo assessment","volume":"12","author":"Fraguas-S\u00e1nchez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2022.09.022_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121198","article-title":"Rapamycin-loaded Poly(lactic-co-glycolic) acid nanoparticles: Preparation, characterization, and in vitro toxicity study for potential intra-articular injection","volume":"609","author":"Pape","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.09.022_b0140","article-title":"The chick embryo chorioallantoic membrane model: a research approach for ex vivo and in vivo experiments","author":"Fraguas-S\u00e1nchez","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejpb.2022.09.022_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2020.104026","article-title":"The use of the chick embryo CAM assay in the study of angiogenic activiy of biomaterials","volume":"131","author":"Ribatti","year":"2020","journal-title":"Microvasc. Res."},{"issue":"11","key":"10.1016\/j.ejpb.2022.09.022_b0150","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/cbin.11051","article-title":"Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents","volume":"42","author":"As","year":"2018","journal-title":"Cell Biol. Int."},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.022_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/foods10020207","article-title":"Use of new glycerol-based dendrimers for essential oils encapsulation: optimization of stirring time and rate using a Plackett-Burman design and a surface response methodology","volume":"10","author":"Maes","year":"2021","journal-title":"Foods"},{"key":"10.1016\/j.ejpb.2022.09.022_b0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.powtec.2012.10.055","article-title":"Application of Plackett-Burman screening design for preparing glibenclamide nanoparticles for dissolution enhancement","volume":"235","author":"Shah","year":"2013","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2022.09.022_b0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejps.2016.12.007","article-title":"Long-circulating polyhydroxybutyrate-co-hydroxyvalerate nanoparticles for tumor targeted docetaxel delivery: formulation, optimization and in vitro characterization","volume":"99","author":"Vardhan","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2022.09.022_b0170","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C9RA10857B","article-title":"PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters","volume":"10","author":"Hern\u00e1ndez-Giottonini","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2022.09.022_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109950","article-title":"A robust systematic design: optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery","volume":"104","author":"Rafiei","year":"2019","journal-title":"Mater. Sci. Eng., C"},{"issue":"1","key":"10.1016\/j.ejpb.2022.09.022_b0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15171\/apb.2018.010","article-title":"Investigation of effective parameters on size of paclitaxel loaded PLGA nanoparticles","volume":"8","author":"Madani","year":"2018","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2022.09.022_b0185","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.colsurfb.2019.06.010","article-title":"PLGA nanoparticles optimized by Box-Behnken for efficient encapsulation of therapeutic Cymbopogon citratus essential oil","volume":"181","author":"Almeida","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.022_b0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/pharmaceutics12020160","article-title":"Long-acting paliperidone parenteral formulations based on polycaprolactone nanoparticles; the influence of stabilizer and chitosan on in vitro release, protein adsorption, and cytotoxicity","volume":"12","author":"Elmowafy","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ejpb.2022.09.022_b0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00126839-200708050-00002","article-title":"Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration","volume":"8","author":"Thakkar","year":"2007","journal-title":"Drugs R D"},{"issue":"2","key":"10.1016\/j.ejpb.2022.09.022_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.ejpb.2022.09.022_b0205","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11051-015-3262-4","article-title":"Chemical approach to solvent removal during nanoencapsulation: its application to preparation of PLGA nanoparticles with non-halogenated solvent","volume":"17","author":"Lee","year":"2015","journal-title":"J. Nanopart. Res."},{"issue":"7","key":"10.1016\/j.ejpb.2022.09.022_b0210","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/10837450.2014.920360","article-title":"Formulation and optimization of celecoxib-loaded PLGA nanoparticles by the Taguchi design and their in vitro cytotoxicity for lung cancer therapy","volume":"20","author":"Emami","year":"2015","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2022.09.022_b0215","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.2147\/IJN.S19497","article-title":"Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells","volume":"6","author":"Kim","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ejpb.2022.09.022_b0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejpb.2019.02.008","article-title":"Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis","volume":"137","author":"Crivelli","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.ejpb.2022.09.022_b0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11095-019-2620-9","article-title":"Synthesis and statistical optimization of poly (lactic-co-glycolic acid) nanoparticles encapsulating GLP1 analog designed for oral delivery","volume":"36","author":"Ismail","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.09.022_b0230","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2147\/IJN.S130908","article-title":"Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis","volume":"12","author":"Marcianes","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.ejpb.2022.09.022_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11040184","article-title":"Design of poly(lactic-co-glycolic acid) (PLGA) nanoparticles for vaginal co-delivery of griffithsin and dapivirine and their synergistic effect for HIV prophylaxis","volume":"11","author":"Yang","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2022.09.022_b0240","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.2147\/IJN.S133832","article-title":"Physicochemical characterization of drug nanocarriers","volume":"12","author":"Manaia","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.ejpb.2022.09.022_b0245","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5650\/jos.ess20299","article-title":"Effects of polyvinyl alcohol on drug release from nanocomposite particles using poly (L-lactide-co-glycolide)","volume":"70","author":"Takeuchi","year":"2021","journal-title":"J. Oleo Sci."},{"issue":"11","key":"10.1016\/j.ejpb.2022.09.022_b0250","doi-asserted-by":"crossref","first-page":"20432","DOI":"10.1002\/jcp.28645","article-title":"RGS1 silencing inhibits the inflammatory response and angiogenesis in rheumatoid arthritis rats through the inactivation of Toll-like receptor signaling pathway","volume":"234","author":"Hu","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.ejpb.2022.09.022_b0255","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10787-014-0200-5","article-title":"Evening primrose oil and celecoxib inhibited pathological angiogenesis, inflammation, and oxidative stress in adjuvant-induced arthritis: novel role of angiopoietin-1","volume":"22","author":"El-Sayed","year":"2014","journal-title":"Inflammopharmacology"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112200217X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112200217X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:50:30Z","timestamp":1760547030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112200217X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":51,"alternative-id":["S093964112200217X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.09.022","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DoE-based development of celecoxib loaded PLGA nanoparticles: In ovo assessment of its antiangiogenic effect","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}